The Short Answer: Risk Depends on the Type and Duration

Hormone replacement therapy (HRT) does increase the risk of certain cancers, but the increase is small and depends heavily on which hormones you take, how long you take them, and your age when you start. Estrogen-only therapy carries a lower cancer risk than estrogen combined with progestin. The risk rises the longer you use HRT, but it also drops after you stop—sometimes within a few years.

The evidence comes from large studies, most notably the Women's Health Initiative (WHI), which tracked thousands of women over many years. These studies found real increases in breast cancer, endometrial cancer (cancer of the uterine lining), and blood clots, but the absolute number of women affected remained relatively small. Understanding what the numbers actually mean helps you weigh the benefits of symptom relief against the risks.

Key Takeaways

  • Estrogen-only HRT increases endometrial cancer risk but does not increase breast cancer risk; combined estrogen-progestin therapy increases both breast and endometrial cancer risk.
  • The longer you take HRT, the higher your cancer risk becomes, and risk is highest in the first few years of use.
  • Your age, weight, family history, and personal medical history all affect how much your individual risk changes.
  • Cancer risk from HRT is real but small in absolute terms—most women who take HRT do not develop cancer.
  • Stopping HRT lowers your cancer risk, and the reduction happens faster for some cancers than others.

Breast Cancer Risk and Estrogen-Progestin Combinations

The Women's Health Initiative study found that women taking combined estrogen-progestin HRT had a higher breast cancer risk than women taking a placebo. The increase appeared after about three years of use and continued to rise the longer women stayed on the therapy. For every 10,000 women taking combined HRT for one year, roughly 8 additional breast cancers occurred compared to women not taking HRT.

Estrogen-only therapy (used by women who have had a hysterectomy) did not show this increased breast cancer risk in the same study. This difference matters because it suggests that progestin, not estrogen alone, drives the breast cancer increase. The type of progestin, the dose, and how often you take it may also affect your risk, though research on these details is still limited.

Your personal risk is not the same as the study average. Women who are overweight, drink alcohol regularly, or have a family history of breast cancer start from a higher baseline risk. For them, adding HRT increases their risk more than it does for women at lower baseline risk. Age also matters: starting HRT in your 50s carries different risk than starting in your 60s.

Endometrial Cancer and Estrogen-Only Therapy

Estrogen-only HRT increases the risk of endometrial cancer (cancer of the uterine lining) significantly more than it increases breast cancer risk. This is why doctors add progestin to estrogen therapy for women who still have a uterus—the progestin protects the uterine lining. Women taking estrogen alone without progestin should not do so for extended periods without medical supervision.

The longer you take estrogen-only therapy, the higher your endometrial cancer risk climbs. Studies show the risk can double or triple after five years of use. However, adding progestin—even cyclically (not every day)—reduces this risk back down to near the level of women not taking HRT. This is why combination therapy is standard for women with a uterus.

How Long You Take HRT Matters

Duration is one of the strongest predictors of cancer risk from HRT. Short-term use (one to two years) carries a much smaller risk increase than long-term use (five years or more). The Women's Health Initiative found that breast cancer risk rose noticeably after three years and continued climbing the longer women stayed on therapy.

This does not mean HRT is safe for short periods and dangerous for long ones—the risk is dose-dependent and cumulative. A woman taking HRT for two years has a lower absolute risk than a woman taking it for ten years, but both have some increased risk compared to not taking HRT at all. Many doctors now recommend using HRT at the lowest effective dose for the shortest time needed to manage symptoms, typically two to five years.

What Happens to Your Risk After You Stop

Cancer risk from HRT does not stay elevated forever after you stop taking it. For breast cancer, the excess risk drops fairly quickly—within a few years of stopping, your risk approaches that of women who never took HRT. For endometrial cancer, the risk reduction happens even faster.

This pattern suggests that HRT does not permanently change your cells in a way that causes cancer years later. Instead, the hormones appear to promote the growth of cancers that already exist or are beginning to form. Once you stop the hormones, that growth-promoting effect stops, and your risk declines.

Other Cancers and Health Risks

Breast and endometrial cancer are the most studied HRT-related cancer risks, but research has looked at others. Ovarian cancer risk may increase slightly with HRT use, though the evidence is less clear than for breast and endometrial cancer. Colorectal cancer risk actually appears to decrease in women taking HRT, as does bone fracture risk.

HRT also increases the risk of blood clots (deep vein thrombosis and pulmonary embolism), particularly in the first year of use. This risk is separate from cancer but important to discuss with your doctor, especially if you have a personal or family history of clots or if you are immobile for long periods.

How to Think About Your Individual Risk

The cancer risks from HRT are real, but they are also small in absolute terms. A 50-year-old woman taking combined HRT for five years increases her breast cancer risk, but her chance of developing breast cancer during that time is still low—roughly 2 to 3 percent instead of 1 to 2 percent, depending on her other risk factors. For many women, the relief from hot flashes, night sweats, and other menopause symptoms outweighs this small increase.

Your doctor should discuss your personal risk factors—age, weight, family history, smoking status, alcohol use, and any previous cancer diagnosis—before you start HRT. Women at very high risk for breast cancer (such as those with a BRCA mutation) may choose not to take HRT or to use it only briefly. Women with no personal or family history of cancer may feel comfortable taking HRT longer. There is no one-size-fits-all answer.

Frequently Asked Questions

Does bioidentical hormone therapy have a lower cancer risk than conventional HRT?

Bioidentical hormones are chemically identical to the hormones your body makes, but there is no strong evidence that they carry a lower cancer risk than conventional HRT. The cancer risk comes from the hormones themselves, not from whether they are bioidentical or synthetic. The dose and duration matter more than the source.

Can I reduce my cancer risk by taking a lower dose of HRT?

Lower doses do appear to carry lower cancer risk than higher doses, though the research on specific dose thresholds is limited. Many doctors now recommend starting at the lowest dose that controls your symptoms and staying there rather than increasing over time. Talk to your doctor about whether a lower dose might work for your symptoms.

What if I have a family history of breast cancer—should I avoid HRT?

A family history of breast cancer does not automatically disqualify you from HRT, but it does mean your baseline risk is higher and the additional risk from HRT matters more. Your doctor may recommend shorter duration, lower doses, or close monitoring with mammograms. If you carry a BRCA mutation, the decision becomes more complex and warrants discussion with a genetic counselor or oncologist.

Does stopping HRT suddenly increase my cancer risk?

Stopping HRT suddenly does not increase your cancer risk compared to stopping gradually. Some women experience a return of hot flashes or other symptoms when they stop, but this is not a cancer risk issue. Your doctor may recommend tapering the dose to manage symptoms, but the cancer risk benefit of stopping is the same whether you stop quickly or slowly.

How often should I get screened for cancer if I take HRT?

Standard cancer screening recommendations (mammograms, Pap smears, and colorectal screening based on age) explore to women taking HRT. Some doctors recommend more frequent mammograms or other monitoring for women on long-term HRT, but there is no universal guideline. Discuss screening frequency with your doctor based on your age and risk factors.